Oyster Point Pharma, Inc.

NasdaqGS:OYST Stock Report

Market Cap: US$303.2m

Oyster Point Pharma Balance Sheet Health

Financial Health criteria checks 0/6

Key information

-415.4%

Debt to equity ratio

US$92.22m

Debt

Interest coverage ration/a
CashUS$68.80m
Equity-US$22.20m
Total liabilitiesUS$131.40m
Total assetsUS$109.20m

Recent financial health updates

Recent updates

Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?

Nov 08
Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?

Oyster Point's nasal spray to be covered by largest Medicare pharmacy benefit manager

Aug 17

Oyster Point Pharma, Inc. (NASDAQ:OYST) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Aug 14
Oyster Point Pharma, Inc. (NASDAQ:OYST) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Oyster Point stock rises 11% after H.C. Wainwright begins coverage with Buy rating

Jul 18

Oyster Therapeutics: State Of Business Is Confounding

Jun 30

Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?

Dec 24
Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?

Oyster Point Pharma (NASDAQ:OYST) Is In A Good Position To Deliver On Growth Plans

Oct 15
Oyster Point Pharma (NASDAQ:OYST) Is In A Good Position To Deliver On Growth Plans

Oyster Point Pharma starts enrollment in mid-stage Neurotrophic Keratopathy study

Jun 21

Here's Why We're Not Too Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Situation

May 10
Here's Why We're Not Too Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Situation

Need To Know: Oyster Point Pharma, Inc. (NASDAQ:OYST) Insiders Have Been Buying Shares

Feb 09
Need To Know: Oyster Point Pharma, Inc. (NASDAQ:OYST) Insiders Have Been Buying Shares

Oyster Point Pharma files US application for its lead program in dry eye disease

Dec 18

Companies Like Oyster Point Pharma (NASDAQ:OYST) Are In A Position To Invest In Growth

Dec 18
Companies Like Oyster Point Pharma (NASDAQ:OYST) Are In A Position To Invest In Growth

Oyster Point Pharma, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 06

Financial Position Analysis

Short Term Liabilities: OYST has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: OYST has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: OYST has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: OYST's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OYST has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: OYST has less than a year of cash runway if free cash flow continues to reduce at historical rates of 49.1% each year


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.